Best Stock of the Day: Trxade Health (MEDS)

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

Founded in 2010 by a pharmacist, Trxade is a platform offering price transparency, cost comparison tools and search features for retail pharmacy customers. As a health services IT company, the firm currently manages the TRxADE procurement marketplace and telehealth services for over 10,000 members

Trxade Health MEDS +3.23 73.1% Change

At $7.65, the stock is up more than 70% overnight, and it’s rising from its lowest lows just a few weeks ago. 

Over the last 12 months, the stock has traded as low as $3 and just short of $11. The recent climb represents what appears to be a long-term upward trend.

Why is MEDS Moving?

MEDS is rising in value after news that Trxade’s Bonum Health label recently signed a telehealth distribution contract with Big Y Pharmacy and Wellness Centers to serve markets in Massachusetts and Connecticut. 

Where to Buy Trxade Health Stock

Buying and selling Trxade Health stock is easier when you use the right brokerage. Review this list of top brokerage houses from Benzinga, searching for the company that gives you the best options, prices and information. 
 

Stay Ahead of the Game on MEDS

Staying ahead of the game on MEDS, or any other stock, is easier when you use Benzinga Pro. Register for Benzinga Pro to see all the information you need on any stock, including the chart pictured above. With quality information, you can diversify your portfolio and increase your net worth.

Data for Trxade Health as of July 1, 2021

Summary of Trxade Health as of July 1, 2021:

• Price Change: $4.42 to $7.65
• 52 Week Low: $3.10
• 52 Week High: $10.82
• Market Cap: $29.414M

Significant Dates for Trxade Health:

• Next Earnings Date: July 26, 2021
• Last Earnings Date: April 26, 2021, EPS of $-0.080

Technical Data of Trxade Health as of July 1, 2021:

• RSI: 61.79 ⮕ Bearish
• MACD: Signal Line (-0.3415) Under MACD (-0.342) ⮕ Bearish
• Bollinger Bands: Price ($7.65), 20-Day SMA ($4.82), Lower Band ($2.61), Upper Band ($7.61) ⮕ Bearish

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.